Majed S. Al Yami

ORCID: 0000-0003-2308-8407
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Acute Myocardial Infarction Research
  • Diagnosis and Treatment of Venous Diseases
  • Pharmaceutical Practices and Patient Outcomes
  • Blood Coagulation and Thrombosis Mechanisms
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • COVID-19 Clinical Research Studies
  • Metabolism, Diabetes, and Cancer
  • Central Venous Catheters and Hemodialysis
  • Medication Adherence and Compliance
  • Antibiotics Pharmacokinetics and Efficacy
  • Diet and metabolism studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Vaccine Coverage and Hesitancy
  • Cardiac Arrhythmias and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • COVID-19 and Mental Health
  • Potassium and Related Disorders
  • Inflammatory Bowel Disease
  • Lipoproteins and Cardiovascular Health
  • Pancreatic function and diabetes

King Saud bin Abdulaziz University for Health Sciences
2017-2025

King Abdulaziz Medical City
2019-2025

King Abdullah International Medical Research Center
2020-2025

National Guard Health Affairs
2019-2025

King Saud University
2022

Action on Smoking and Health
2020

University of Arizona
2017-2018

Data exploring parents' hesitancy to vaccinate their 5-11-year-old children against COVID-19, and associated factors, is limited. This study aims investigate beliefs intentions using the Health Belief Model in Saudi Arabia. A national, cross-sectional, questionnaire-based was conducted November, 2021. The self-administered online questionnaire distributed a random sample of parents. Adult parents with at least one child were included. main outcome intention children. Variability assessed by...

10.3389/fpubh.2022.842862 article EN cc-by Frontiers in Public Health 2022-03-30

Background Despite the empirical literature demonstrating efficacy of antidepressant medications for treatment depression disorder, these medications’ effect on patients’ overall well-being and health-related quality life (HRQoL) remains controversial. This study investigates medication use patient-reported HRQoL patients who have depression. Methods A comparative cohort, secondary database analysis was conducted using data from United States’ Medical Expenditures Panel Survey had measured...

10.1371/journal.pone.0265928 article EN cc-by PLoS ONE 2022-04-20

The purpose of this study was to evaluate the observed incidence acute kidney injury (AKI) in adult patients receiving either piperacillin-tazobactam (PT) and vancomycin or meropenem for at least 48h. In retrospective cohort study, we included with no known renal dysfunction who received combination PT-vancomycin meropenem-vancomycin study's primary outcome (AKI), defined by Kidney Disease: Improving Global Outcomes (KDIGO) baseline normal function as an increase serum creatinine (Scr)...

10.1016/j.jiph.2016.11.007 article EN cc-by-nc-nd Journal of Infection and Public Health 2017-02-13

Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney (CKD), and obesity are associated with increased morbidity mortality in patients type 2 diabetes mellitus (T2DM). Nonetheless, their prevalence among T2DM Saudi Arabia (SA) remains unknown. As current guidelines recommend, these comorbidities require adding certain antidiabetic agents cardiorenal benefits. However, the prescribers' adherence to recommendations unclear. A two-center retrospective...

10.1016/j.jsps.2024.102054 article EN cc-by-nc-nd Saudi Pharmaceutical Journal 2024-03-28

Background: Deep vein thrombosis (DVT) is a leading cause of death disability. DVT can be classified based on the location and extent clot into isolated distal (iDDVT), proximal (iPDVT), or mixed DVT. The aim this study to explore baseline characteristics clinical outcomes patients with different types Methods: This was retrospective who experienced their first event received an anticoagulant for management. include evaluating patients’ assessing incidence recurrent DVT, major bleeding (MB),...

10.1177/10760296241313055 article EN cc-by-nc Clinical and Applied Thrombosis/Hemostasis 2025-01-01

Objective: The objective of this study was to evaluate the effects adherence ACC/AHA 2018 dyslipidemia guidelines on patient management lipid-lowering therapy in patients with ischemic heart diseases (IHD) and its correlation major adverse cardiovascular events (MACEs), including non-fatal MI, stroke, death, hospitalization for revascularization, peripheral arterial disease. Methods: A multi-center retrospective observational conducted IHD between January 2019 December 2020, who were...

10.3390/jcm14030908 article EN Journal of Clinical Medicine 2025-01-30

Background and Objective Direct oral anticoagulants (DOACs) have been proven to be cost-effective for treating various conditions, including venous thromboembolism (VTE). Nevertheless, there are no studies assessing the cost-effectiveness of DOACs VTE treatment in Saudi Arabia using real-world data. Hence, this study seeks examine costs medical consequences apixaban compared rivaroxaban patients Arabia. Methods A retrospective cohort was carried out three tertiary care hospitals spanning...

10.1177/10760296251318705 article EN cc-by-nc Clinical and Applied Thrombosis/Hemostasis 2025-01-01

Patients with liver disease express multiple pathophysiological variations that alter the pharmacokinetics of numerous drugs. At this time, there is insufficient evidence about proper dosing vancomycin in patients disease. This study aimed to assess risk acute kidney injury (AKI) during therapy and identify predictors AKI all-cause mortality among varying degrees dysfunction. A retrospective cohort was conducted including chronic who used hospitalization from January 2016 2024 two Saudi...

10.1186/s12879-025-10763-3 article EN cc-by-nc-nd BMC Infectious Diseases 2025-03-18

Drug-drug interactions (DDIs) are significant causes of adverse drug reactions among patients with cancer. We aimed to identify the prevalence, severity, and predictors potential DDIs geriatric oncology patients. A cross-sectional, retrospective study was conducted at two tertiary medical centers. Geriatric (≥ 65 years) who were diagnosed solid tumors received outpatient prescriptions a minimum drugs between January 2018 December 2022 included in study. Patients' medications screened for...

10.1186/s12877-025-05965-y article EN cc-by-nc-nd BMC Geriatrics 2025-05-01

Background The use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes mellitus (T2DM) remains limited, especially those other compelling indications. Thus, this study aimed to describe the prescribing patterns GLP-1-RA SGLT2i T2DM determine factors that affect these medications. Methods This multicenter retrospective cross-sectional reviewed electronic health records adult diagnosed who received care...

10.3389/fpubh.2022.1031306 article EN cc-by Frontiers in Public Health 2022-10-28

: GLP-1 receptor agonists (GLP-1RA) are used in the management of type II diabetes mellitus or obesity, although its role patients with I (T1DM) has been debated. This study aimed to investigate efficacy and safety GLP-1RA T1DM using real-world data.

10.3390/jcm13216532 article EN Journal of Clinical Medicine 2024-10-30
Coming Soon ...